Quantcast

Latest bladder cancer Stories

COXEN Model Chooses Best Drug For Treatment Of Ovarian Cancer
2014-02-19 08:40:31

Garth Sundem - University of Colorado Cancer Center There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month’s issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics...

2014-02-17 23:21:07

Scientists find a “modest but clinically significant” link between the diabetes drug and bladder cancer. Raleigh, NC (PRWEB) February 17, 2014 The authors of a new study published in the British Journal of Clinical Pharmacology and detailed by Cancer Monthly recommend that doctors who treat diabetes limit their patients’ exposure to the drug piaglitazone (Actos) to reduce their risk of bladder cancer. The research team from Liverpool conducted a search of the medical literature for...

2014-02-14 23:20:53

Researchers say the diabetes drug does not appear to reduce the risk of bladder cancer in patients with type 2 diabetes. Raleigh, NC (PRWEB) February 14, 2014 New research conducted at the University of Pennsylvania’s Abramson Cancer Center and reported by Cancer Monthly finds that patients on the popular type 2 diabetes drug metformin (Glucophage) have about the same risk of getting bladder cancer as patients on another class of drugs called sulfonylureas . Both types of drugs carry a...

2014-02-08 23:03:08

National network of attorneys is providing consumer updates and no-cost consultations over allegations that the use of the diabetes medication Actos can cause patients to develop bladder cancer. San Diego, CA (PRWEB) February 08, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced today its latest update for consumers who are following litigation* involving allegations that the use of Actos to treat diabetes can cause...

2014-02-04 12:27:33

Study shows that in 95% of cases CellDetect(TM) distinguished staining and succeeded in identifying the cancerous cells TEL AVIV, Israel, Feb. 4, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, has expanded its...

2014-01-30 23:03:55

In the second whole-genome sequencing study ever conducted in bladder cancer, a Roswell Park-led team observed two distinct patterns of aberrations, and identified a potential target for therapy. Buffalo, NY (PRWEB) January 30, 2014 In the first whole-genome analysis conducted through the Roswell Park Cancer Institute (RPCI) Center for Personalized Medicine, researchers report that invasive bladder cancers demonstrate two distinct patterns of genetic alteration, one of which may result...

2014-01-30 12:28:48

International studies demonstrate importance of comprehensive tumor profiling for poor-prognosis cancer patients IRVING, Texas, Jan. 30, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present two tumor profiling studies at the 2014 Genitourinary Cancers Symposium held this week in San Francisco, Calif. Through use of the company's comprehensive tumor profiling service, Caris Molecular Intelligence,...

2014-01-29 23:29:07

Schlichter, Bogard & Denton, LLP is investigating and pursuing claims on behalf of individuals who allege that they have been diagnosed with bladder cancer after taking the diabetes medication Actos® for more than one year. St. Louis, MO (PRWEB) January 29, 2014 The first trial in the Multidistrict Litigation In re: Actos® (Pioglitazone) Products Liability Litigation, MDL 2299, begins on Monday, January 27, 2014 with opening statements expected to occur on February 3, 2014....

2014-01-28 23:00:18

First Actos bellwether trial is underway, with the jury having been selected on Monday. Thousands of Plaintiffs in the Actos litigation developed bladder cancer, allegedly because of Actos (pioglitazone). New York, New York (PRWEB) January 28, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports that the first Actos bellwether trial has commenced. According to court documents, the jury was...

2014-01-26 23:02:18

The Firm is representing clients in Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused bladder cancer. New Yor, New York (PRWEB) January 26, 2014 Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) alleging long-term use of the Type 2 diabetes drug can cause bladder cancer continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports....


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related